| 名稱 | FLT3-ITD N676K/BaF3 |
| 型號(hào) | CBP73242 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FLT3-ITD [N676K]/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 新型冠狀病毒：用于診斷的假病毒標(biāo)準(zhǔn)品和用于藥物研發(fā)的假病毒模型
- 【藥靶模型】ESR1 Y537S模型開發(fā)
- 重磅！科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- 細(xì)胞株開發(fā)的主要過(guò)程要知道
- 潛力十足的T細(xì)胞療法，我們用得起嗎？
- IL9細(xì)胞篩選模型
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- BTK細(xì)胞篩選模型
- 能量平衡的重要靶點(diǎn)——CRF1R和CRF2R
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73242FLT3-ITD N676K/BaF3
- 詳細(xì)內(nèi)容
| CBP73242 | |
| I. Introduction | |
Cell Line Name： | FLT3-ITD [N676K]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FLT3, receptor-type tyrosine-protein kinase FLT3, activates Akt, Ras, and Erk pathways to regulate differentiation, proliferation, and survival of hematopoietic progenitor cells (PMID: 29316714, PMID: 28538663). Activating mutations of FLT3 are common in hematologic tumors (PMID: 19467916) and the internal tandem duplication (ITD) mutation is commonly observed in acute myeloid leukemia (PMID: 30181385). | |
| III. Representative Data | |
1.FLT3-ITD [N676K]/BaF3
| |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of two reference compounds on the FLT3-ITD [N676K]/BaF3 Stable Cell Line. | |
會(huì)員_a.png)